Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma. - Gomes-da-Silva NC; Cavalcanti A; Alves G; Meohas W; Facchetti B; Perini JA; Rebelo Alencar LM; Ricci-Junior E; Fechine PBA; Barja-Fidalgo TC; Rosas EC; Santos-Oliveira R (European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2026)